Citigroup’s Biohaven BHVN Stock Holding History

Citigroup’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-50,000	Closed	-$1.2M	–	5653
2025 Q1	$1.2M	Buy	+50,000	New	+$1.76M	﹤0.01%	3119

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup's BHVN Position: Q2 2026 in Review

Citigroup increased its Biohaven (BHVN) stake by 792% in Q2 2026, buying an estimated $3.01M and bringing the position to 314,453 shares worth $4.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2201.

Citigroup first reported a position in BHVN in Q3 2022 and has held it in 16 quarters since. The position peaked at $9.05M in Q1 2024. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

Citigroup held 314,453 shares of Biohaven worth $4.68M as of Q2 2026.
Citigroup bought 279,216 Biohaven shares in Q2 2026, an estimated $3.01M.
Biohaven made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2201 holding.
Citigroup first reported a position in Biohaven in Q3 2022 and has held it in 16 quarters since.
Citigroup's Biohaven position peaked at $9.05M in Q1 2024.
296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.